 |
 |
- Search
Search
- Page Path
-
- HOME
- Search
- Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial
- M.A. Elbaset, Diaa-Eldin Taha, Ahmed S. El-Hefnawy, Mohamad H. Zahran, A.A Shokeir
- Int Neurourol J. 2019;23(3):240-248. Published online 2019 September 30
-
- Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
- Yankai Xu, Ruihua Liu, Chu Liu, Yuanshan Cui, Zhenli Gao
- Int Neurourol J. 2017;21(3):212-219. Published online 2017 September 12
-
- Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms
- Kirill Vladimirovich Kosilov, Loparev Sergay Alexandrovich, Kuzina Irina Gennadyevna, Shakirova Olga Viktorovna, Zhuravskaya Natalia Sergeevna, Ankudinov Ivan Ivanovich
- Int Neurourol J. 2016;20(3):240-249. Published online 2016 September 23
-
- Clinical Factors Associated With Dose Escalation of Solifenacin for the Treatment of Overactive Bladder in Real Life Practice
- Ji-Youn Chun, Miho Song, Ji-Yeon Han, Selee Na, Bumsik Hong, Myung-Soo Choo
- Int Neurourol J. 2014;18(1):23-30. Published online 2014 March 31
-
| 1 | |
- Official Journal of Korean Continence Society & ESSIC (International Society for the Study of BPS) & Korean Society of Urological Research & The Korean Children’s Continence and Enuresis Society & The Korean Association of Urogenital Tract Infection and Inflammation & Korean Society of Geriatric Urological Care
- Editorial Office
-
Department of Urology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine,
29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea
Tel: +82-2-2001-2237 Fax: +82-2-2001-2247 E-mail: choys1011@naver.com
Copyright © 2024 by Korean Continence Society.
